Koyfin Home > Directory > Health Care > Aldeyra Therapeu > EBITDA

Aldeyra Therapeu EBITDA Chart (ALDX)

Aldeyra Therapeu annual/quarterly EBITDA from 2012 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Aldeyra Therapeu EBITDA for the quarter ending June 06, 2020 was $-7m a -170.70% increase of 12m year over year
  • Aldeyra Therapeu EBITDA for the last 12 months ending June 06, 2020 was $-48m a -12.87% increase of 6m year over year
  • Aldeyra Therapeu Annual EBITDA for 2019 was $-56m a 29.75% decrease of -17m from 2018
  • Aldeyra Therapeu Annual EBITDA for 2018 was $-40m a 43.35% decrease of -17m from 2017
  • Aldeyra Therapeu Annual EBITDA for 2017 was $-22m a 16.88% decrease of -4m from 2016
Other Income Statement Metrics:
  • Aldeyra Therapeu Net Income for the quarter ending September 09, 2018 was $-11m a 35.68% decrease of -4m year over year
View Chart On Koyfin

Quarterly ALDX EBITDA Data

06/2020$-7m
03/2020$-10m
12/2019$-13m
09/2019$-19m
06/2019$-14m
03/2019$-11m
12/2018$-11m
09/2018$-11m
06/2018$-9m
03/2018$-8m

Annual ALDX EBITDA Data

2019$-56m
2018$-40m
2017$-22m
2016$-19m
2015$-12m
2014$-7m
2013$-4m
2012$-1m
2011$-2m